Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

Summary

The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.

Timeline

Start

2015-01

Primary completion

2018-01-16

Completion

2018-01-16

Drugs

Indications